Physician profile
William A Haas
NPI 1467424408
$377.58
in general payments reported to CMS, 2019-2025
10 companies · $83.37 in 2025
The $83.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.02 · 2021: $11.72 · 2022: $54.67 · 2023: $116 · 2024: $59.10 · 2025: $83.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $108.17 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $77.95 | 2019-2022 | |
| Lilly USA, LLC | $29.57 | 2023-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $29.55 | 2019-2023 | |
| Glaxosmithkline, LLC. | $28.93 | 2023-2025 | Shingrix, Arexvy |
| Abbott Laboratories | $24.92 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.93 | 2024 | |
| Si-Bone, INC. | $20.29 | 2025 | |
| Ucb, INC. | $19.18 | 2025 | Bimzelx |
| Boston Scientific Corporation | $15.09 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.